Ruth E. Stevens, PhD, MBA, Chief Scientific Officer and Executive Vice President

Dr. Stevens has over 16 years of experience in the development of new drugs and therapeutic agents. In addition to her work for Camargo, Dr. Stevens is an adjunct associate professor of pharmacokinetics at the University of Cincinnati, College of Pharmacy. She has authored 44 abstracts/publications and has been an invited speaker both nationally and internationally.

Prior to joining Camargo, Dr. Stevens was senior director of clinical affairs at Duramed Pharmaceuticals, Inc. (now Barr Pharmaceuticals) overseeing Phase I-IV scientific and clinical activities, with emphasis on women’s health and HRT products. She also served as director of pharmacokinetics and pharmacodynamics at Phoenix International Life Sciences, Inc. (now MDS Pharma Services), where she was responsible for scientific management of Clinical Pharmacology Phase I and II studies.

Dr. Stevens began her career at the U.S. Food and Drug Administration (FDA) as a pharmacokinetic reviewer and a team leader in the Office of Clinical Pharmacology and Biopharmaceutics in the Center for Drug Evaluation and Research (CDER).